These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18235898)

  • 1. Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study.
    Russ HH; Costa VP; Ferreira FM; Valgas SR; Correa Neto MA; Strobel Ev; Truppel JH
    Arq Bras Oftalmol; 2007; 70(6):910-6. PubMed ID: 18235898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study.
    Liang H; Brignole-Baudouin F; Pauly A; Riancho L; Baudouin C
    Adv Ther; 2011 Apr; 28(4):311-25. PubMed ID: 21424577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
    Kahook MY; Noecker RJ
    Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial.
    Russ HH; Nogueira-Filho PA; Barros Jde N; Faria NV; Montiani-Ferreira F; Gomes JÁ; Mello PA
    Clinics (Sao Paulo); 2013 Oct; 68(10):1318-24. PubMed ID: 24212838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects.
    Stewart WC; Stewart JA; Jenkins JN; Jackson AL
    J Glaucoma; 2003 Dec; 12(6):475-9. PubMed ID: 14646682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study.
    Agnifili L; Mastropasqua R; Fasanella V; Brescia L; Scatena B; Oddone F; Mastropasqua L
    J Glaucoma; 2018 Apr; 27(4):364-370. PubMed ID: 29401160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.
    Paranhos A; Mendonça M; Silva MJ; Giampani J; Torres RJ; Della Paolera M; Russ H; Lottenberg CL
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):611-5. PubMed ID: 21029020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.
    Eisenberg DL; Toris CB; Camras CB
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S105-15. PubMed ID: 12204706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
    Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
    Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of intraocular pressure lowering efficacy of bimatoprost / timolol fixed combination and other glaucoma medications in the treatment of glaucoma].
    Skorkovská K
    Cesk Slov Oftalmol; 2008 Jul; 64(4):144-8. PubMed ID: 18780653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.
    Nixon DR
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):876-81. PubMed ID: 24070367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of additional topical cyclosporine or vitamin A on the ocular surface during antiglaucoma medication administration.
    Cho HK; Park MH; Moon JI
    Ophthalmic Res; 2012; 48(3):139-45. PubMed ID: 22572974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Topouzis F; Melamed S; Danesh-Meyer H; Wells AP; Kozobolis V; Wieland H; Andrew R; Wells D
    Eur J Ophthalmol; 2007; 17(2):183-90. PubMed ID: 17415690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
    Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost.
    Stewart WC; Kolker AE; Stewart JA; Leech J; Jackson AL
    Am J Ophthalmol; 2003 Mar; 135(3):314-20. PubMed ID: 12614748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival changes and inflammatory aspects in rabbits' conjunctivas induced by fixed combinations of prostaglandin analogues and timolol maleate.
    de Faria NV; Russ HH; Rose P; Noronha L; Mello PA; Montiani-Ferreira F; Sobrinho SC
    J Ophthalmic Inflamm Infect; 2013 Jan; 3(1):22. PubMed ID: 23514095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bimatoprost/timolol: a review of its use in glaucoma and ocular hypertension.
    Curran MP; Orman JS
    Drugs Aging; 2009; 26(2):169-84. PubMed ID: 19220073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal alterations induced by topical application of commercial latanoprost, travoprost and bimatoprost in rabbit.
    Chen W; Dong N; Huang C; Zhang Z; Hu J; Xie H; Pan J; Liu Z
    PLoS One; 2014; 9(3):e89205. PubMed ID: 24632558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma.
    Martinez A; Sanchez M
    Curr Med Res Opin; 2007 May; 23(5):1025-32. PubMed ID: 17519068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.